Kim et al. (2018) demonstrated that miR-141 expression was related to TM4SF1 in pancreatic cancer, and upregulating miR-141, which decreased TM4SF1, reduced E-cadherin and VEGF-A to accelerate EMT in pancreatic cancer cells. This evidence concerns the gene TM4SF1 and familial pancreatic carcinoma.